Search This Blog

Thursday, July 6, 2023

Neurocrine Bio: BMO Capital Markets upgrades to market perform from underperform.

  PT up 1.5% to $96.

https://www.marketscreener.com/quote/stock/NEUROCRINE-BIOSCIENCES-I-10163/

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)